ArticleHeliyon2024

Investigating efficacy of colchicine plus phenolic monoterpenes fraction as a potential treatment for patients diagnosed with COVID-19: A randomized controlled parallel clinical trial.

Siavash Vaziri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.